OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
1306 Publications
found
Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina.
b
Ecancermedicalscience
January 1, 2021
p
Cancer
c
Change patient management
Observational
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.
b
Targeted oncology
January 1, 2021
p
Cancer
c
Change patient management
Observational
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
b
Therapeutic advances in medical oncology
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review.
b
Frontiers in oncology
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Review
EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong – A cost-effectiveness analysis.
b
PloS one
January 1, 2021
p
Cancer
c
Economics
Model
Impact of Precision Medicine on Clinical Outcomes: A Single-Institution Retrospective Study.
b
Frontiers in oncology
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
b
Therapeutic advances in medical oncology
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Observational
A Phase II Trial of Osimertinib as the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1.
b
Cancer research and treatment
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Impact of Direct From Blood Culture Identification of Pathogens Paired With Antimicrobial Stewardship Interventions in a Pediatric Hospital.
b
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
January 1, 2021
p
MALDI-TOF MS For Microorganism Identification
c
Change patient management
Observational
Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study.
b
PloS one
January 1, 2021
p
Diabetes
c
Change patient management
Clinical outcomes
Observational
Previous Page
1
…
43
44
45
46
47
…
131
Next Page